MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Transcranial Magnetic Stimulation as Treatment for Functional Movement Disorders: Experiences from a Single Centre Retrospective Audit

    I. Osborne, J. Peters, S. Tisch (Darlinghurst, Australia)

    Objective: St Vincent’s Hospital Sydney has been offering Transcranial Magnetic Stimulation (TMS) to adult patients with a diagnosis of Functional Movement Disorders (FMD) since 2020.…
  • 2025 International Congress

    Apraxia of Speech as a Presenting Feature in AP3B2 Antibody Associated Cerebellar Ataxia

    E. Ruether, A. Aksamit, D. Dubey, J. Stierwalt, S. Syc-Mazurek (Rochester, USA)

    Objective: We describe a unique presentation of AP3B2 antibody with apraxia of speech and cerebellar ataxia. Background: Adaptor Protein 3B2 (AP3B2) is a subunit of…
  • 2025 International Congress

    A Novel Dopaminergic Modulator (NDM-101) as an Adjunct to Levodopa: Enhancing Motor Control Without Worsening Dyskinesia in Parkinson’s Disease

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the efficacy and safety of NDM-101 as an adjunct to levodopa in reducing OFF-time, improving motor function, and maintaining quality of life…
  • 2025 International Congress

    Sex differences in regional densities of Lewy body pathology

    C. Tremblay, S. Chiu, G. Serrano, C. Adler, H. Shill, E. Driver-Dunckley, S. Mehta, C. Belden, D. Shprecher, Y. Zeighami, M. Dadar, A. Atri, T. Beach, P. Choudhury (Montreal, Canada)

    Objective: To assess sex differences in regional Lewy body pathology densities and their clinical correlations in cases with Lewy body (LB) pathology at autopsy. Background:…
  • 2025 International Congress

    The Effectiveness of Drug-Disease Best Practice Advisory Alerts for Preventing the Administration of Contraindicated Medications in Patients with Parkinsonism

    A. Kundrick, M. Fedorova, B. Sokola, B. Walter (Cleveland, USA)

    Objective: To determine the effectiveness of drug-disease best practice advisory alerts at preventing the administration of contraindicated medications in patients with parkinsonism as a quality…
  • 2025 International Congress

    Designing a Cultural Dance Program for People with Parkinson’s Disease

    J. Takata, K. Tolentino, R. Shuman, M. Look, K. Thai, E. Krening, F. Gao, L. Jaffe, T. Seto, M. Bruno (Honolulu, USA)

    Objective: Design a culturally-based movement program to improve the experience of living with Parkinson’s disease. Background: Prior research has shown that dance therapy enhances the…
  • 2025 International Congress

    Improving Guitar Strumming Mechanics in Parkinson’s Disease: A Case Series Using a Forearm Stabilization Device

    J. Lenger, S. Matsushita, T. Lesiuk, M. Kerulis, N. Punjabi (Miami, USA)

    Objective: This case series aims to explore the potential benefits of a guitar adaptation in enhancing mechanics of guitar strumming among this patient sample. Specifically,…
  • 2025 International Congress

    Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

    WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)

    Objective: This review/protocol proposal explores whether combining three concepts Counterclockwise theory, Imagery training, and Art therapy can improve motor symptoms and enhance the quality of…
  • 2025 International Congress

    Barriers To Physical Exercise Adherence In Individuals With Parkinson’s Disease: A Cross-Sectional Study

    S. Souza, G. Leveck, T. Christinelli, L. Paladini, V. Israel (Curitiba, Brazil)

    Objective: To identify the main self-reported barriers to PE adherence in individuals with PD. Background: Parkinson’s disease (PD) is a neurodegenerative syndrome that leads to…
  • 2025 International Congress

    Cerebrospinal fluid DOPA decarboxylase levels as a marker of disease severity in Parkinson’s Disease

    K. Groenewald, L. van Hillegondsberg, T. Eisenstein, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To assess the correlation of CSF DDC levels to DaT-SPECT SBR in PD and iRBD. Background: Raised cerebrospinal fluid (CSF) proteomic biomarker, DOPA decarboxylase…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley